Dr. William M. Lee, M.D., FACP, FAASLD, is a founding and active member of the Board of Directors for the VVHA. Dr. Lee has served as Professor of Internal Medicine and Bioengineering at the University of Texas Southwestern Medical Center at Dallas since 1990. He holds the Meredith Mosle Chair in Liver Diseases in his honor.

Dr. Lee initially characterized Gc protein as an actin scavenger in acute liver failure and has delineated many of the clinical features of acetaminophen hepatotoxicity. In 1997, he founded the Acute Liver Failure Study Group (ALFSG), a national network to study this orphan disease, funded continuously since then by the National Institutes of Health. In addition, he has been a Principal Investigator with the HALT-C Trial, the Drug-Induced Liver Injury Network (DILIN) and the Hepatitis B Research Network. A past Secretary-Treasurer of AASLD, he has given both the Leon Schiff and the Hyman Zimmerman Memorial Lectures at the Annual Meeting and authored more than 200 original manuscripts and 130 chapters and reviews.

While maintaining an active practice, Dr. Lee has mentored more than 75 individual students, residents, younger colleagues and visiting fellows over 4 decades, from as far away as Copenhagen, Kampala, Shanghai and Melbourne. In November 2014, he was awarded the Distinguished Clinician Educator/Mentor Award from the American Association for the Study of Liver Diseases.

Dr. Lee graduated from Amherst College, cum laude, and the College of Physicians and Surgeons of Columbia University AOA, completing his internal medicine residency at the Presbyterian Hospital in New York City where he served as Chief Resident. After additional studies at Kings College Hospital, London, he has served on the faculties of Columbia University; the Medical University of South Carolina; and The Ohio State University.